WPD Pharmaceuticals Inc (OTCMKTS: WPDPF) announced that CNS Pharmaceuticals Inc (NASDAQ: CNSP) received a Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its investigational lead drug, Berubicin. Designation permits company to frequent interactions with FDA Berubicin is used for the management of patients with recurring glioblastoma […]